{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:44:45Z","timestamp":1774435485731,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,5,19]],"date-time":"2016-05-19T00:00:00Z","timestamp":1463616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wellcome Trust","award":["098481\/Z\/12\/Z"],"award-info":[{"award-number":["098481\/Z\/12\/Z"]}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12916-016-0614-6","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T15:50:22Z","timestamp":1461685822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Enhanced antibiotic distribution strategies and the potential impact of facial cleanliness and environmental improvements for the sustained control of trachoma: a modelling study"],"prefix":"10.1186","volume":"14","author":[{"given":"Amy","family":"Pinsent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Gambhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,19]]},"reference":[{"issue":"39","key":"614_CR1","first-page":"421","volume":"89","author":"WHO Alliance for the Global Elimination of Blinding Trachoma by the year 2020","year":"2014","unstructured":"WHO Alliance for the Global Elimination of Blinding Trachoma by the year 2020. Progress report on elimination of trachoma, 2013. Wkly Epidemiol Rec. 2014;89(39):421\u20138.","journal-title":"Wkly Epidemiol Rec"},{"issue":"9960","key":"614_CR2","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(13)62182-0","volume":"384","author":"HR Taylor","year":"2014","unstructured":"Taylor HR, Burton MJ, Haddad D, West S, Wright H. Trachoma. Lancet. 2014;384(9960):2142\u201352.","journal-title":"Lancet"},{"key":"614_CR3","unstructured":"World Health Organization (WHO). Report of the 3rd global scientific meeting on trachoma. Johns Hopkins University, Baltimore, Maryland, 19\u201320 July 2010. WHO: Geneva; 2010."},{"issue":"2","key":"614_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/infdis\/jir257","volume":"204","author":"SK West","year":"2011","unstructured":"West SK, Munoz B, Mkocha H, Gaydos CA, Quinn TC. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania. J Infect Dis. 2011;204(2):268\u201373.","journal-title":"J Infect Dis"},{"issue":"2","key":"614_CR5","doi-asserted-by":"publisher","first-page":"e376","DOI":"10.1371\/journal.pntd.0000376","volume":"3","author":"T Lakew","year":"2009","unstructured":"Lakew T, House J, Hong KC, Yi E, Alemayehu W, Melese M, et al. Reduction and return of infectious trachoma in severely affected communities in Ethiopia. PLoS Negl Trop Dis. 2009;3(2):e376.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"614_CR6","doi-asserted-by":"publisher","first-page":"e0003610","DOI":"10.1371\/journal.pntd.0003610","volume":"9","author":"V Jimenez","year":"2015","unstructured":"Jimenez V, Gelderblom HC, Mann Flueckiger R, Emerson PM, Haddad D. Mass drug administration for trachoma: how long is not long enough? PLoS Negl Trop Dis. 2015;9(3):e0003610.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9379","key":"614_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0140-6736(03)13909-8","volume":"362","author":"AW Solomon","year":"2003","unstructured":"Solomon AW, Holland MJ, Burton MJ, West SK, Alexander NDE, Aguirre A, et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet. 2003;362(9379):198\u2013204.","journal-title":"Lancet"},{"issue":"1","key":"614_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1167\/iovs.04-0327","volume":"46","author":"ES West","year":"2005","unstructured":"West ES, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, et al. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community. Inves Ophthalmol Vis Sci. 2005;46(1):83\u20137.","journal-title":"Inves Ophthalmol Vis Sci"},{"issue":"3","key":"614_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/09286580902863015","volume":"16","author":"JP Campbell","year":"2009","unstructured":"Campbell JP, Mkocha H, Munoz B, West SK. Randomized trial of high dose azithromycin compared to standard dosing for children with severe trachoma in Tanzania. Ophthalmic Epidemiol. 2009;16(3):175\u201380.","journal-title":"Ophthalmic Epidemiol"},{"issue":"9467","key":"614_CR10","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0140-6736(05)61029-X","volume":"365","author":"MJ Burton","year":"2005","unstructured":"Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, Sillah A, et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet. 2005;365(9467):1321\u20138.","journal-title":"Lancet"},{"issue":"1","key":"614_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/09286586.2011.627490","volume":"19","author":"JP Campbell","year":"2012","unstructured":"Campbell JP, Mkocha H, Munoz B, West SK. Two-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania. Ophthalmic Epidemiol. 2012;19(1):38\u201342.","journal-title":"Ophthalmic Epidemiol"},{"issue":"2","key":"614_CR12","doi-asserted-by":"publisher","first-page":"e1001605","DOI":"10.1371\/journal.pmed.1001605","volume":"11","author":"ME Stocks","year":"2014","unstructured":"Stocks ME, Ogden S, Haddad D, Addiss DG, McGuire C, Freeman MC. Effect of water, sanitation, and hygiene on the prevention of trachoma: a systematic review and meta-analysis. PLoS Med. 2014;11(2):e1001605.","journal-title":"PLoS Med"},{"issue":"5","key":"614_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/8451","volume":"5","author":"T Lietman","year":"1999","unstructured":"Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med. 1999;5(5):572\u20136.","journal-title":"Nat Med"},{"key":"614_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-2334-7-91","volume":"7","author":"KJ Ray","year":"2007","unstructured":"Ray KJ, Porco TC, Hong KC, Lee DC, Alemayehu W, Melese M, et al. A rationale for continuing mass antibiotic distributions for trachoma. BMC Infect Dis. 2007;7:91.","journal-title":"BMC Infect Dis"},{"issue":"12","key":"614_CR15","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1371\/journal.pntd.0000341","volume":"2","author":"NC Grassly","year":"2008","unstructured":"Grassly NC, Ward ME, Ferris S, Mabey DC, Bailey RL. The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up. PLoS Negl Trop Dis. 2008;2(12):e341.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"614_CR16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S1473-3099(07)70137-8","volume":"7","author":"M Gambhir","year":"2007","unstructured":"Gambhir M, Basanez MG, Turner F, Kumaresan J, Grassly NC. Trachoma: transmission, infection, and control. Lancet Infect Dis. 2007;7(6):420\u20137.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"614_CR17","doi-asserted-by":"publisher","first-page":"e462","DOI":"10.1371\/journal.pntd.0000462","volume":"3","author":"M Gambhir","year":"2009","unstructured":"Gambhir M, Basanez MG, Burton MJ, Solomon AW, Bailey RL, Holland MJ, et al. The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control. PLoS Negl Trop Dis. 2009;3(6):e462.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9811","key":"614_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0140-6736(11)61515-8","volume":"379","author":"T Gebre","year":"2012","unstructured":"Gebre T, Ayele B, Zerihun M, Genet A, Stoller NE, Zhou Z, et al. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial. Lancet. 2012;379(9811):143\u201351.","journal-title":"Lancet"},{"issue":"8","key":"614_CR19","doi-asserted-by":"publisher","first-page":"e2415","DOI":"10.1371\/journal.pntd.0002415","volume":"7","author":"SK West","year":"2013","unstructured":"West SK, Bailey R, Munoz B, Edwards T, Mkocha H, Gaydos C, et al. A randomized trial of two coverage targets for mass treatment with azithromycin for trachoma. PLoS Negl Trop Dis. 2013;7(8):e2415.","journal-title":"PLoS Negl Trop Dis"},{"key":"614_CR20","doi-asserted-by":"crossref","unstructured":"Gambhir M, Pinsent A. Possible changes in the transmissibility of trachoma following MDA and transmission reduction: implications for the GET2020 goals. Parasit Vectors. 2015;8(530).","DOI":"10.1186\/s13071-015-1133-6"},{"issue":"2","key":"614_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.epidem.2011.03.004","volume":"3","author":"TM Lietman","year":"2011","unstructured":"Lietman TM, Gebre T, Ayele B, Ray KJ, Maher MC, See CW, et al. The epidemiological dynamics of infectious trachoma may facilitate elimination. Epidemics. 2011;3(2):119\u201324.","journal-title":"Epidemics"},{"key":"614_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.epidem.2015.03.003","volume":"11","author":"TM Lietman","year":"2015","unstructured":"Lietman TM, Gebre T, Abdou A, Alemayehu W, Emerson P, Blumberg S, et al. The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing. Epidemics. 2015;11:85\u201391.","journal-title":"Epidemics"},{"issue":"6","key":"614_CR23","doi-asserted-by":"publisher","first-page":"e458","DOI":"10.1371\/journal.pntd.0000458","volume":"3","author":"KJ Ray","year":"2009","unstructured":"Ray KJ, Lietman TM, Porco TC, Keenan JD, Bailey RL, Solomon AW, et al. When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries. PLoS Negl Trop Dis. 2009;3(6):e458.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"614_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00007435-200209000-00001","volume":"29","author":"CY Lau","year":"2002","unstructured":"Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002;29(9):497\u2013502.","journal-title":"Sex Transm Dis"},{"issue":"1","key":"614_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/infdis\/jiu046","volume":"210","author":"SK West","year":"2014","unstructured":"West SK, Moncada J, Munoz B, Mkocha H, Storey P, Hardick J, et al. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control? J Infect Dis. 2014;210(1):65\u201371.","journal-title":"J Infect Dis"},{"issue":"5","key":"614_CR26","doi-asserted-by":"publisher","first-page":"e37778","DOI":"10.1371\/journal.pone.0037778","volume":"7","author":"J Walker","year":"2012","unstructured":"Walker J, Tabrizi SN, Fairley CK, Chen MY, Bradshaw CS, Twin J, et al. Chlamydia trachomatis incidence and re-infection among young women--behavioural and microbiological characteristics. PLoS One. 2012;7(5):e37778.","journal-title":"PLoS One"},{"issue":"11","key":"614_CR27","doi-asserted-by":"publisher","first-page":"e81236","DOI":"10.1371\/journal.pone.0081236","volume":"8","author":"NH Dukers-Muijrers","year":"2013","unstructured":"Dukers-Muijrers NH, Speksnijder AG, Morr\u00e9 SA, Wolffs PF, van der Sande MA, Brink AA, et al. Detection of anorectal and cervicovaginal Chlamydia trachomatis infections following azithromycin treatment: prospective cohort study with multiple time-sequential measures of rRNA, DNA, quantitative load and symptoms. PLoS One. 2013;8(11):e81236.","journal-title":"PLoS One"},{"issue":"3","key":"614_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/sextrans-2014-051633","volume":"91","author":"MS van Rooijen","year":"2015","unstructured":"van Rooijen MS, van der Loeff MF, Morr\u00e9 SA, van Dam AP, Speksnijder AG, de Vries HJ. Spontaneous pharyngeal Chlamydia trachomatis RNA clearance. A cross-sectional study followed by a cohort study of untreated STI clinic patients in Amsterdam, The Netherlands. Sex Transm Infect. 2015;91(3):157\u201364.","journal-title":"Sex Transm Infect"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0614-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-016-0614-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0614-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0614-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T17:07:01Z","timestamp":1589476021000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-016-0614-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,19]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1186\/s12916-016-0614-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,19]]},"assertion":[{"value":"8 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"71"}}